DE69914947D1 - Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen - Google Patents
Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungenInfo
- Publication number
- DE69914947D1 DE69914947D1 DE69914947T DE69914947T DE69914947D1 DE 69914947 D1 DE69914947 D1 DE 69914947D1 DE 69914947 T DE69914947 T DE 69914947T DE 69914947 T DE69914947 T DE 69914947T DE 69914947 D1 DE69914947 D1 DE 69914947D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- soy protein
- diabetes
- phytoestrogen
- cardiovascular diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010073771 Soybean Proteins Proteins 0.000 title abstract 4
- 229940001941 soy protein Drugs 0.000 title abstract 4
- 235000013325 dietary fiber Nutrition 0.000 title abstract 3
- 239000003075 phytoestrogen Substances 0.000 title abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 102000015781 Dietary Proteins Human genes 0.000 title 1
- 208000001145 Metabolic Syndrome Diseases 0.000 title 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
- 235000008696 isoflavones Nutrition 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801556 | 1998-11-25 | ||
DKPA199900856 | 1999-06-16 | ||
PCT/IB1999/001992 WO2000030663A1 (en) | 1998-11-25 | 1999-11-25 | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69914947D1 true DE69914947D1 (de) | 2004-03-25 |
Family
ID=26064784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69914947T Expired - Lifetime DE69914947D1 (de) | 1998-11-25 | 1999-11-25 | Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1143988B1 (de) |
JP (1) | JP2003524610A (de) |
AT (1) | ATE259646T1 (de) |
AU (1) | AU1511300A (de) |
BR (1) | BR9915693A (de) |
CA (1) | CA2352510A1 (de) |
DE (1) | DE69914947D1 (de) |
HK (1) | HK1041636A1 (de) |
WO (1) | WO2000030663A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1171119A1 (de) | 1999-04-20 | 2002-01-16 | The Board Of Trustees Of Southern Illinois University | Methoden zur behandlung klinischer erkrankungen mit isoflavonen |
AU779014B2 (en) * | 1999-04-23 | 2005-01-06 | Archer-Daniels-Midland Company | Composition for and method of reducing low density lipoprotein cholesterol concentration |
US6544566B1 (en) | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
AU783820B2 (en) * | 1999-04-23 | 2005-12-08 | Archer-Daniels-Midland Company | Composition for and method of reducing low density lipoprotein cholesterol concentration |
US7285297B1 (en) | 1999-04-23 | 2007-10-23 | Archer-Daniels-Midland Company | Method of reducing low density liproprotein cholesterol concentration |
KR20030005280A (ko) | 2000-04-14 | 2003-01-17 | 마아즈, 인코오포레이티드 | 혈관의 건강을 개선하기 위한 조성물과 방법 |
JP2011105763A (ja) * | 2000-06-21 | 2011-06-02 | Kao Corp | Ppar依存的遺伝子転写活性化剤 |
US6365176B1 (en) * | 2000-08-08 | 2002-04-02 | Functional Foods, Inc. | Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy |
EP1361870A2 (de) * | 2001-02-01 | 2003-11-19 | Nutri Pharma ASA | Eine substanz zur verwendung in einem diätzusatz oder zur herstellung eines medikaments zur behandlung von nicht-insulin-abhängigen diabetes mellitus, bluthochdruck und/oder des metabolischen syndroms |
FI20010780A0 (fi) | 2001-04-12 | 2001-04-12 | Raisio Benecol Oy | Parannetut koostumukset |
US6559177B2 (en) | 2001-04-19 | 2003-05-06 | Wyeth | 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents |
US6589980B2 (en) | 2001-05-17 | 2003-07-08 | Wyeth | Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents |
AU2002345255A1 (en) * | 2001-07-03 | 2003-01-21 | Nutri Pharma Danmark Holding A/S | Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
US6787151B2 (en) | 2001-08-10 | 2004-09-07 | Lipton, Division Of Conopco, Inc. | Composition for lowering blood cholesterol |
GB0125662D0 (en) * | 2001-10-26 | 2001-12-19 | Chapman Thomas B | Formultion |
WO2003070018A2 (en) * | 2002-02-22 | 2003-08-28 | Nutri Pharma Asa | Food products comprising soy protein |
AU2003215774A1 (en) * | 2002-02-23 | 2003-09-09 | Nutri Pharma Asa | Method for manufacturing beads containing exogenous soy protein |
EP1480525A2 (de) * | 2002-02-23 | 2004-12-01 | Nutri Pharma ASA | Neue sojaproteinprodukte |
NZ536466A (en) * | 2002-04-18 | 2008-04-30 | Monsanto Technology Llc | Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
CA2492754C (en) | 2002-07-24 | 2018-05-22 | Children's Hospital Medical Center | Compositions and products containing enantiomeric equol, and methods for their making |
US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
CA2504682A1 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
JP2008007452A (ja) * | 2006-06-28 | 2008-01-17 | Ajinomoto Co Inc | 膵β細胞保護剤 |
BRPI0715740A8 (pt) * | 2006-08-21 | 2017-01-24 | Calpis Co Ltd | Agente redutor de triglicerídeos séricos |
DE102006040456A1 (de) * | 2006-08-25 | 2008-02-28 | Constantin Nies | Verzehrbare flächige Darreichungsform von Nahrungsergänzungsmitteln und/oder Arzneiwirkstoffen zur Ergänzung von fertigen oder halbfertigen Nahrungsmitteln |
US9101161B2 (en) | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
CN102919739B (zh) | 2007-06-13 | 2014-07-02 | 大塚制药株式会社 | 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品 |
JP2011006369A (ja) * | 2009-06-29 | 2011-01-13 | Kao Corp | Pai−1低下剤 |
CA2990230A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
WO2016205701A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Enteral fast access tract platform system |
USD767243S1 (en) | 2015-09-03 | 2016-09-27 | The J.M. Smucker Company | Coated food product |
USD767244S1 (en) | 2015-09-03 | 2016-09-27 | The J.M. Smucker Company | Coated food product |
USD767241S1 (en) | 2015-09-03 | 2016-09-27 | The J.M. Smucker Company | Coated food product |
USD767242S1 (en) | 2015-09-03 | 2016-09-27 | The J.M Smucker Company | Coated food product |
WO2021064107A1 (en) | 2019-10-02 | 2021-04-08 | Norvia Nutrition Ltd. | Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2395288A1 (fr) * | 1977-06-23 | 1979-01-19 | Ppn | Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore |
DK171752B1 (da) * | 1992-07-06 | 1997-05-12 | Birgitte Stilling | Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf |
CA2249366C (en) * | 1996-04-09 | 2001-06-12 | Donald Lee Crank | Novel isoflavone-enriched soy protein product and method for its manufacture |
AU3887597A (en) * | 1996-07-18 | 1998-02-10 | Nutricor, Inc. | Nutritious food preparations and methods for making them |
EP1310173B2 (de) * | 1997-06-23 | 2014-12-31 | Société des Produits Nestlé S.A. | Zusammensetzung zur Ernährung von Diabetikern |
-
1999
- 1999-11-25 JP JP2000583546A patent/JP2003524610A/ja active Pending
- 1999-11-25 EP EP99957390A patent/EP1143988B1/de not_active Revoked
- 1999-11-25 DE DE69914947T patent/DE69914947D1/de not_active Expired - Lifetime
- 1999-11-25 BR BR9915693-8A patent/BR9915693A/pt not_active IP Right Cessation
- 1999-11-25 WO PCT/IB1999/001992 patent/WO2000030663A1/en not_active Application Discontinuation
- 1999-11-25 AU AU15113/00A patent/AU1511300A/en not_active Abandoned
- 1999-11-25 CA CA002352510A patent/CA2352510A1/en not_active Abandoned
- 1999-11-25 AT AT99957390T patent/ATE259646T1/de not_active IP Right Cessation
-
2002
- 2002-03-05 HK HK02101699.0A patent/HK1041636A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU1511300A (en) | 2000-06-13 |
WO2000030663A1 (en) | 2000-06-02 |
HK1041636A1 (zh) | 2002-07-19 |
CA2352510A1 (en) | 2000-06-02 |
EP1143988A1 (de) | 2001-10-17 |
JP2003524610A (ja) | 2003-08-19 |
BR9915693A (pt) | 2001-08-14 |
EP1143988B1 (de) | 2004-02-18 |
ATE259646T1 (de) | 2004-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69914947D1 (de) | Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen | |
ATE253925T1 (de) | Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen | |
ATE242638T1 (de) | Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen | |
ATE279163T1 (de) | Gewebedezellularization | |
CY1112356T1 (el) | Καλτσα | |
TR200000077T1 (tr) | Dekubitus ülserlerinin tedavisi için besin terkibi. | |
DE69931907D1 (de) | Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen | |
ATE259644T1 (de) | Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd | |
WO1999004748A3 (en) | Skin care composition | |
DE69713300D1 (de) | Benzopyran derivate mit leukotrien-antagonistischer wirkung | |
TR200103634T2 (tr) | Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi. | |
PT942741E (pt) | Composicoes de lectina e suas utilizacoes | |
RU2003117446A (ru) | Косметический способ лечения кожи | |
ATE289816T1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
DE60336187D1 (de) | Verwendung von einem Extrakt von einem nicht-photosynthetischen faserigen Bakterium zur Beförderung der Herstellung von Superoxid-dismutase | |
BR0009592A (pt) | Composição anti-diabética, e, método para tratamento de diabetes mellitus | |
ATE61524T1 (de) | Verwendung von hyperoxygenierten oelen zur herstellung eines arzneimittells zur behandlung von herpes. | |
DE60304461T8 (de) | Verwendung von pflanzlichem material zur bekämpfung von landschnecken | |
DE50210605D1 (de) | Gewürzkrautzubereitung | |
ATE450267T1 (de) | Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse | |
BR0209403A (pt) | Uso de fvii modificado, e, método para tratar o dano pulmonar agudo ou a sìndrome da doença respiratória aguda em seres humanos | |
ES2147144B1 (es) | Mejoras introducidas en el objeto de la patente n- 9702336 por: procedimiento de utilizacion de la madera en la madera en la obtencion de un producto sustitutivo de la turba natural. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |